Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
100 participants
INTERVENTIONAL
2017-04-15
2017-11-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The random distribution is made prior to assignment following the internet program https://www.random.org
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test (clorhexidine gel)
The healing abutments were covered by a chlorhexidine gel after the first week of the second surgery (2-stage implants).
Chlorhexidine
Healing abutment with Clorhexidine
Placebo
The healing abutments were covered without any antiseptic gel after the first week of the second surgery (2-stage implants).
Placebo
Healing abutment without any antiseptic
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chlorhexidine
Healing abutment with Clorhexidine
Placebo
Healing abutment without any antiseptic
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No current pain.
* No use of painkillers or Anti-inflammatory drugs in the prior weeks.
* Older than 18 years.
* Oral hygiene index of ≤ 2 (Löe and Silness).
* A minimum of 2 mm of adhered gum.
* A minimum of 8 mm of vertical bone.
* A minimum of 7 mm of vestibule-lingual bone.
* Scheduled to receive a unitary implant.
* Willing to participate in this controlled study.
Exclusion Criteria
* Use of any type of medication that might affect the perception of pain.
* An history of alcohol or drug abuse.
* A requirement for guided regeneration or sinus lifting procedures.
* Failure to comply with the study protocol.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Murcia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Arturo Sánchez-Pérez
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arturo Sánchez-Pérez, Professor
Role: PRINCIPAL_INVESTIGATOR
Universidad de Murcia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Odontologic Universitary Clinic
Murcia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1366/2016
Identifier Type: -
Identifier Source: org_study_id